Skip to main content
logo
Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
18.47
-0.07 (-0.38%)
At close: Mar 18, 2026, 4:00 PM EDT
18.00
-0.47 (-2.54%)
After-hours: Mar 18, 2026, 5:27 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Molecular Profiling Services Revenue
766.72M349.12M
Molecular Profiling Services Revenue Growth
119.62%25.24%
Pharma Research and Development Services Revenue
45.31M63.15M
Pharma Research and Development Services Revenue Growth
-28.24%130.63%
Revenue (Total)
812.03M412.26M
Revenue (Total) Growth
96.97%34.67%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States Revenue
801.39M401.84M
United States Revenue Growth
99.43%36.95%
International Revenue
10.64M10.42M
International Revenue Growth
2.07%-18.05%
Revenue (Total)
812.03M412.26M
Revenue (Total) Growth
96.97%34.67%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Molecular Intelligence (MI) Profile - Clinical Case Volume
170.30K146.60K
Molecular Intelligence (MI) Profile - Clinical Case Volume Growth
16.17%-
Caris Assure - Clinical Case Volume
29.00K16.30K
Caris Assure - Clinical Case Volume Growth
77.91%-
Total Clinical Case Volume
199.30K162.90K
Total Clinical Case Volume Growth
22.35%26.47%
Molecular Intelligence (MI) Profile - Clinical Average Selling Price (ASP)
4.03K2.20K
Molecular Intelligence (MI) Profile - Clinical Average Selling Price (ASP) Growth
83.17%-
Caris Assure - Clinical Average Selling Price (ASP)
2.80K1.65K
Caris Assure - Clinical Average Selling Price (ASP) Growth
69.29%-
Updated Dec 31, 2025. Data Source: Fiscal.ai.